BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16556044)

  • 1. LRP5/6 in Wnt signaling and tumorigenesis.
    Li Y; Bu G
    Future Oncol; 2005 Oct; 1(5):673-81. PubMed ID: 16556044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.
    Bryja V; Andersson ER; Schambony A; Esner M; Bryjová L; Biris KK; Hall AC; Kraft B; Cajanek L; Yamaguchi TP; Buckingham M; Arenas E
    Mol Biol Cell; 2009 Feb; 20(3):924-36. PubMed ID: 19056682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.
    Williams BO; Insogna KL
    J Bone Miner Res; 2009 Feb; 24(2):171-8. PubMed ID: 19072724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
    Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
    J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for signaling specificity of Wnt/Frizzled combinations through co-receptor recruitment.
    Verkaar F; Zaman GJ
    FEBS Lett; 2010 Sep; 584(18):3850-4. PubMed ID: 20800062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6.
    Fleury D; Vayssiere B; Touitou R; Gillard C; Lebhar H; Rawadi G; Mollat P
    Protein Expr Purif; 2010 Mar; 70(1):39-47. PubMed ID: 19716419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
    Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
    Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.
    Semënov M; Tamai K; He X
    J Biol Chem; 2005 Jul; 280(29):26770-5. PubMed ID: 15908424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.
    Wang Z; Shu W; Lu MM; Morrisey EE
    Mol Cell Biol; 2005 Jun; 25(12):5022-30. PubMed ID: 15923619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
    Glass DA; Karsenty G
    Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
    Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
    Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation.
    Ding Y; Xi Y; Chen T; Wang JY; Tao DL; Wu ZL; Li YP; Li C; Zeng R; Li L
    J Cell Biol; 2008 Sep; 182(5):865-72. PubMed ID: 18762581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
    Johnson ML
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):135-8. PubMed ID: 15615112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Wnt signaling: an unexpected new player.
    Habas R
    Dev Cell; 2006 Aug; 11(2):138-9. PubMed ID: 16890154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the mechanisms of Wnt signaling antagonism by Dkk.
    Chen L; Wang K; Shao Y; Huang J; Li X; Shan J; Wu D; Zheng JJ
    J Biol Chem; 2008 Aug; 283(34):23364-70. PubMed ID: 18524778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
    Cong F; Schweizer L; Varmus H
    Development; 2004 Oct; 131(20):5103-15. PubMed ID: 15459103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells.
    Guo Y; Zi X; Koontz Z; Kim A; Xie J; Gorlick R; Holcombe RF; Hoang BH
    J Orthop Res; 2007 Jul; 25(7):964-71. PubMed ID: 17318900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signalling: antagonistic Dickkopfs.
    Zorn AM
    Curr Biol; 2001 Aug; 11(15):R592-5. PubMed ID: 11516963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C in Wnt signaling: implications in cancer initiation and progression.
    Luna-Ulloa LB; Hernández-Maqueda JG; Castañeda-Patlán MC; Robles-Flores M
    IUBMB Life; 2011 Oct; 63(10):915-21. PubMed ID: 21905203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.